Kevin Outterson

Summary

Affiliation: Boston University
Country: USA

Publications

  1. ncbi Will longer antimicrobial patents improve global public health?
    Kevin Outterson
    Boston University School of Law, Boston, MA 02215, USA
    Lancet Infect Dis 7:559-66. 2007
  2. ncbi Market-based licensing for HPV vaccines in developing countries
    Kevin Outterson
    Boston University School of Law, USA
    Health Aff (Millwood) 27:130-9. 2008
  3. ncbi How Medicare could get better prices on prescription drugs
    Kevin Outterson
    Boston University School of Law, Massachusetts, USA
    Health Aff (Millwood) 28:w832-41. 2009
  4. ncbi Fighting antibiotic resistance: marrying new financial incentives to meeting public health goals
    Aaron S Kesselheim
    Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA, USA
    Health Aff (Millwood) 29:1689-96. 2010
  5. ncbi Pharmaceutical arbitrage: balancing access and innovation in international prescription drug markets
    Kevin Outterson
    West Virginia University College of Law, USA
    Yale J Health Policy Law Ethics 5:193-291. 2005
  6. ncbi Patent buy-outs for global disease innovations for low- and middle-income countries
    Kevin Outterson
    West Virginia University, USA
    Am J Law Med 32:159-73. 2006

Detail Information

Publications6

  1. ncbi Will longer antimicrobial patents improve global public health?
    Kevin Outterson
    Boston University School of Law, Boston, MA 02215, USA
    Lancet Infect Dis 7:559-66. 2007
    ..Conservation efforts to encourage the prudent use of antimicrobial drugs should be directly reimbursed. Patent owners should be compensated for both conservation efforts and valuable innovation...
  2. ncbi Market-based licensing for HPV vaccines in developing countries
    Kevin Outterson
    Boston University School of Law, USA
    Health Aff (Millwood) 27:130-9. 2008
    ....
  3. ncbi How Medicare could get better prices on prescription drugs
    Kevin Outterson
    Boston University School of Law, Massachusetts, USA
    Health Aff (Millwood) 28:w832-41. 2009
    ..These latter options may reduce federal spending without direct government price negotiations...
  4. ncbi Fighting antibiotic resistance: marrying new financial incentives to meeting public health goals
    Aaron S Kesselheim
    Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA, USA
    Health Aff (Millwood) 29:1689-96. 2010
    ..This would increase reimbursement for the appropriate, evidence-based use of antibiotics that also met specific public health goals--such as reducing illness levels while limiting antibiotic resistance...
  5. ncbi Pharmaceutical arbitrage: balancing access and innovation in international prescription drug markets
    Kevin Outterson
    West Virginia University College of Law, USA
    Yale J Health Policy Law Ethics 5:193-291. 2005
  6. ncbi Patent buy-outs for global disease innovations for low- and middle-income countries
    Kevin Outterson
    West Virginia University, USA
    Am J Law Med 32:159-73. 2006